Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Value in Health

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1524-4733.2007.00214.xPMID 18237360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PO3 CLASSIFYING AND PREDICTING ANTIPSYCHOTIC ADHERENCE AMONG SCHIZOPHRENIA OUTPATIENTS IN EUROPE: A LATENT CLASS ANALYSIS

  2005cited by this paper
• Open Access to Innovative Drugs: Treatment Substitutions or Treatment Expansion?

  2004cited by this paper
• The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population.

  2004cited by this paper
• Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.

  2004cited by this paper
• Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

  2004cited by this paper
• Applied Latent Class Analysis

  2003cited by this paper
• Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis.

  2003cited by this paper
• A review of the literature on the economics of noncompliance. Room for methodological improvement.

  2002cited by this paper
• Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders.

  2002cited by this paper
• From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication.

  2002cited by this paper
• Latent Class Factor and Cluster Models, Bi-Plots, and Related Graphical Displays

  2001cited by this paper
• The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.

  2000cited by this paper
• Antipsychotic drug use patterns and the cost of treating schizophrenia.

  2000cited by this paper
• Atypical neuroleptics: autonomy and compliance?

  1999cited by this paper
• The assessment of refill compliance using pharmacy records: methods, validity, and applications.

  1997cited by this paper
• Latent class analysis in medical research

  1996cited by this paper
• Bayesian Data Analysis

  1995cited by this paper
• Treatment Adherence

  1976cited by this paper
• Latent structure analysis

  1969cited by this paper

• Latent variable analysis of adherence to antipsychotics among south carolina medicaid beneficiaries with schizophrenia or schizoaffective disorder.

  2025cites this paper
• Financial incentives and long-acting injectable antipsychotics engagement: community mental health professionals’ perspectives

  2025cites this paper
• Treatment discontinuation and switching of antipsychotics among adult patients with schizophrenia in the United States.

  2025cites this paper
• Delay in psychiatric hospitalization from the diagnosis of first-episode schizophrenia and its association with clinical outcomes and direct medical costs: a nationwide, health insurance data-based study

  2022cites this paper
• Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries

  2022cites this paper
• Maternal depressive symptoms, attendance of sessions and reduction of home safety problems in a randomized toddler safety promotion intervention trial: A latent class analysis

  2022cites this paper
• Pattern classification as decision support tool in antipsychotic treatment algorithms.

  2021cites this paper
• Association between behavioral phenotypes and sustained use of smartphones and wearable devices to remotely monitor physical activity

  2021cites this paper
• Association of antipsychotics adherence and cardiovascular disease among newly diagnosed schizophrenia patients: A national cohort among Koreans.

  2020cites this paper
• Pharmacist’s Role in Improving Medication Adherence in Transplant Recipients With Comorbid Psychiatric Disorders

  2019cites this paper
• Distinct subgroups of emergency department frequent users: A latent class analysis.

  2019cites this paper
• Attitude and perceptions of patients towards long acting depot injections (LAIs).

  2019cites this paper
• National database study on the use of long‐acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan

  2019cites this paper
• Does Non-Adherence Increase Treatment Costs in Schizophrenia?

  2018influential citation
• INTERVENTIONS TO IMPROVE THERAPEUTIC ADHERENCE IN SUBJECTS WIT

  2018cites this paper
• Latent Class Analysis (LCA) Based Approach for Finding Best Hotels

  2018cites this paper
• Identification of Cross-sector Service Utilization Patterns Among Urban Medicaid Expansion Enrollees

  2018cites this paper
• Meeting the Needs of Rural Adults with Mental Illness and Dual Diagnoses

  2018cites this paper
• Intervenciones para mejorar la adherencia terapéutica en sujetos con esquizofrenia

  2018influential citation
• Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis

  2017cites this paper
• Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting

  2017cites this paper
• Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists

  2016cites this paper
• Gr upSM Treatment of Schizophrenia with Long-Acting Injectable Antipsychotics

  2016cites this paper
• New-Generation Antipsychotics Long- Acting Injectable Formulations and Drug- Delivery Technologies

  2016cites this paper
• Assessment of the Burden of Care and Quality of Life of Caregivers in Schizophrenia

  2016cites this paper
• Assessment of Antipsychotic Combination Therapy among Patients with Schizophrenia on Follow-up at Amanuel Specialized Mental Hospital

  2016cites this paper
• Substance use, mental illness, and familial conflict non-negotiation among HIV-positive African-Americans: latent class regression and a new syndemic framework

  2016influential citation
• Mental health and health care utilization among transition age youth

  2015cites this paper
• Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data

  2015cites this paper
• Prevalence and predictors of medication non-adherence among Chinese patients with first-episode psychosis.

  2015cites this paper
• A Post-Authorisation Safety Survey Evaluating Risperidone Long-Acting Injectable in Romania

  2015cites this paper
• Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment

  2015cites this paper
• Latent Class Models in action: bridging social capital & Internet usage.

  2015cites this paper
• Psychotropic Medication Adherence among Community-Based Individuals with Developmental Disabilities and Mental Illness

  2015influential citation
• A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?

  2014cites this paper
• Poor Adherence to Antipsychotic Medication in People with Schizophrenia: Diffusion, Consequences and Contributing Factors

  2014influential citation
• Long-acting injectable antipsychotics: an underutilized treatment option.

  2014cites this paper
• Affective temperaments and psychotropic adherence.

  2013cites this paper
• Polypharmacy in Psychiatry Practice, Volume II

  2013cites this paper
• Polypharmacy in Psychiatry Practice, Volume I

  2013cites this paper
• Comparison of Immigrant and Native-Born Population Adherence to Antipsychotic Treatment in a Spanish Health Region

  2013cites this paper
• Effectiveness of sulpiride in adult patients with schizophrenia.

  2013cites this paper
• The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries.

  2013cites this paper
• The Adequacy of Pharmaceutical Treatment of Schizophrenia in Quebec Varies with Age, but is Not Influenced by Sex or Neighbourhood Deprivation

  2013cites this paper
• Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany

  2013cites this paper
• New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia

  2013cites this paper
• Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia

  2013cites this paper
• Antipsychotic Polypharmacy in Schizophrenia. How to Counteract This Common Practice

  2013cites this paper
• Preclinical and Clinical Investigation of Antipsychotic Polypharmacy: What Is the Evidence?

  2013cites this paper
• Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review

  2013influential citation
• Ús de fàrmacs antidepressius i antipsicòtics per part de la població immigrant i autòctona de la regió sanitària de Lleida. Anàlisi de les desigualtats en l’exposició i en l’adherència al tractament

  2012cites this paper
• Adesão ao tratamento medicamentoso em pacientes do espectro esquizofrênico: uma revisão sistemática da literatura

  2012cites this paper
• Patients' acceptance of the deltoid application of risperidone long-acting injection.

  2012cites this paper
• 중증 정신 질환 환자에서의 약물 순응도 향상

  2012cites this paper
• Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States

  2012cites this paper
• Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice.

  2012cites this paper
• Long-acting antipsychotic medications.

  2012cites this paper
• Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study.

  2012cites this paper
• Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

  2012cites this paper
• Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective

  2012cites this paper
• Improving Medication Adherence in Patients with Severe Mental Illness

  2012cites this paper
• Adesão ao tratamento medicamentoso em pacientes do espectro esquizofrênico: uma revisão sistemática da literatura Adherence to drug treatment among schizophrenic spectrum patients: a systematic review of the literature

  2012cites this paper
• Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations

  2012cites this paper
• Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia

  2012cites this paper
• The schizophrenia caregiver quality of life questionnaire (S-CGQoL): development and validation of an instrument to measure quality of life of caregivers of individuals with schizophrenia

  2011cites this paper
• Psychiatrists’ attitude to antipsychotic depot treatment in patients with first-episode schizophrenia

  2011cites this paper
• Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.

  2011cites this paper
• Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model

  2011cites this paper
• Factors Associated with Medication Non-Adherence in Patients Suffering from Schizophrenia: A Cross-Sectional Study in a Universal Coverage Health-Care System

  2010cites this paper
• Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines

  2010cites this paper
• An Analysis of Electronically Monitored Adherence to Antiretroviral Medications

  2010cites this paper
• Development and Delivery of a Quality Improvement Program to Reduce Antipsychotic Polytherapy

  2010cites this paper
• Indirect Costs Associated With Nonadherence to Treatment for Bipolar Disorder

  2010cites this paper
• Subtypes of Sleep Disturbance: Associations Among Symptoms, Comorbidities, Treatment, and Medical Costs

  2010cites this paper
• Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia

  2009cites this paper
• Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

  2009cites this paper
• The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

  2009cites this paper
• Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysis.

  2008cites this paper
• Not for Sale or Commercial Distribution

  2007cites this paper
• Research Institute.

  2006cites this paper
• Clinicoeconomics and Outcomes Research Dovepress Long-term Cost-effectiveness of Atypical Antipsychotics in the Treatment of Adults with Schizophrenia in the Us

  year unknowncites this paper